Virus Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Gene Therapy
Scientists at University of the Witwatersrand describe research in gene therapy
August 14th, 2007
Data detailed in "Opportunities for treating chronic hepatitis B and C virus infection using RNA interference" have been presented. "Activating the RNA interference (RNAi) pathway to achieve silencing of specific genes is one of the most exciting new developments of molecular biology. A particularly interesting use of this technology is inhibition of defined viral gene expression," researchers in Johannesburg, South Africa report. "In this review, we discuss the potential application of RNAi to treatment of chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection. Globally, these hepatotropic viruses are the most important causes of cirrhosis and liver...
Source: Virus Weekly (2007-08-14)
|
